DH faces challenges due to macro pressures impacting new business and growth prospects. Despite that, Definitive Healthcare is rated as a buy. Click here to see why.

Macro Headwinds Dragged Definitive Healthcare Corp. (DH) in Q4 Published on February 27, 2023 at 7:09 am by Soumya Eswaran in Hedge Fund Investor Letters, News ...